By: Lancet From: medicalxpress.com Artificial intelligence (AI)-supported mammography identifies more cancers during screening and reduces the rate of breast cancer diagnosis by 12% in the years following, finds the first randomized controlled trial of its kind. The trial involved over 100,000 Swedish women, and its results are published in The Lancet. The interim safety results of the MASAI trial, published …
What to know about the CA 15-3 test and breast cancer
From: medicalnewstoday.com The cancer antigen 15-3 (CA 15-3) test is a blood test that can indicate how a person is responding to treatment for invasive breast cancer or check for the recurrence of breast cancer. Healthy cells in the breast release a protein called CA 15-3. When a person has breast cancer, cancerous cells or tumors in the breast can …
A population-based study of invitation to and participation in clinical trials among women with early-stage breast cancer
By: DocWire News Featured Reading From: docwirenews.com ABSTRACT PURPOSE: Although many studies clearly demonstrate disparities in cancer clinical trial enrollment, there is a lack of consensus on potential causes. Furthermore, virtually nothing is known about associations between patients’ decision-making style and their participation in clinical trials. METHODS: Women with newly diagnosed, stage 0-II breast cancer reported to the Georgia and …